CD27 and neoplasm: CD27 G2 CAR-T cells had enhanced antigen-stimulated effector functions, upregulated expression of anti-apoptotic proteins (e.g., Bcl-X(L)), increased in vivo persistence, and enhanced tumor regression in an SKOV3 human ovarian cancer cell mouse model compared to G1 CAR T cells [79].